2) Reduced side effects (better tolerability) GI side effects like nausea, constipation, reflux, and diarrhea are common reasons people quit early
GLP-1 (glucagon-like peptide-1) medications represent a breakthrough in medical weight loss treatment
Thank you Faseeha and team
On Medicare Part D, Express Scripts Medicare plans reportedly do not cover Wegovy for obesity (they do cover Wegovy for cardiovascular indication), reflecting CMS policy ( [38] )
GLP-1 receptor agonists are not recommended during pregnancy, and patients should discontinue treatment if pregnancy occurs
While GLP-1 medications can be administered at any time of day (consistent with prescribing information), some patients report personal preference for evening administration